NEW YORK, June 14, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE: OGN) and certain of the ...

THE LAWSUIT: A class action securities lawsuit was filed against Organon & Co. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between October 31, ...

IF YOU SUFFERED A LOSS ON YOUR ORGANON INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS. On May 1, 2025, Organon ...

Organon (OGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

LOS ANGELES, June 13, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for violations of the ...

INCHEON, Korea & JERSEY CITY, N.J., May 27, 2025--Organon and Samsung Bioepis' HADLIMA granted FDA interchangeability designation approval for all high- and-low concentration presentations.

More Bonds of Organon & Co./ Organon Foreign Debt Co-Issuer B.V. About the Organon & Co./ Organon Foreign Debt Co-Issuer B.V.-Bond (XS2332250708) The Organon & Co./ Organon Foreign Debt Co-Issuer ...